BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15673421)

  • 1. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
    Berry MF; Pirolli TJ; Jayasankar V; Morine KJ; Moise MA; Fisher O; Gardner TJ; Patterson PH; Woo YJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):866-75. PubMed ID: 15573071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer.
    Wang W; Yang ZJ; Ma DC; Wang LS; Xu SL; Zhang YR; Cao KJ; Zhang FM; Ma WZ
    Acta Pharmacol Sin; 2006 May; 27(5):555-60. PubMed ID: 16626510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Berry MF; Burdick J; Bhalla RC; Sharma RV; Gardner TJ; Sweeney HL
    Circulation; 2004 Sep; 110(11 Suppl 1):II180-6. PubMed ID: 15364860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
    Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
    Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
    Guo Y; Liu C; He J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease.
    Hu S; Chen Y; Li L; Chen J; Wu B; Zhou X; Zhi G; Li Q; Wang R; Duan H; Guo Z; Yang Y; Xiao F; Wang H; Wang L
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1537-44. PubMed ID: 19931736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
    Jin H; Yang R; Li W; Ogasawara AK; Schwall R; Eberhard DA; Zheng Z; Kahn D; Paoni NF
    J Pharmacol Exp Ther; 2003 Feb; 304(2):654-60. PubMed ID: 12538818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
    Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
    Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
    J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.